TP53 and breast carcinoma: Moreover, miR-214 directly targets p53 to promote breast cancer cell invasion, and overexpression of p53 reverses this oncogenic effect, suggesting miR-214 as a potential therapeutic target for inhibiting invasion in breast cancer (Wang et al., 2015).